Metoprolol dosage for hypertension
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol Dosage for Hypertension: An Overview
Introduction to Metoprolol for Hypertension
Metoprolol, a selective beta-adrenergic receptor antagonist, is widely used in the management of hypertension. Its efficacy in reducing blood pressure and heart rate has been well-documented across various studies. This article synthesizes research findings on the optimal dosages and administration schedules for metoprolol in hypertensive patients.
Dosage and Administration Schedules
Twice-Daily vs. Once-Daily Administration
Research comparing once-daily and twice-daily administration of metoprolol has shown that both regimens are effective in controlling blood pressure. A study involving 20 patients with mild to moderate hypertension found that both twice-daily (100 mg) and once-daily (200 mg) regimens significantly reduced blood pressure, with no significant difference between the two schedules . Another study confirmed that once-daily controlled-release metoprolol (50 mg) was as effective as conventional metoprolol (50 mg twice daily) in reducing blood pressure and heart rate 79.
Dosage Ranges and Efficacy
The effective dosage of metoprolol can vary. In a study with 16 patients, a dosage of 25 mg three times daily initially, followed by 100 mg three times daily, resulted in significant reductions in blood pressure . Another study involving 32 patients found that 150 mg and 300 mg once-daily doses were effective, with a higher percentage of responders at the 300 mg dose . Additionally, a study on the kinetics and dose-response characteristics of metoprolol indicated that doses above 200 mg/day did not significantly increase efficacy, suggesting a relatively horizontal dose-response curve at higher doses .
Long-Term Efficacy and Kinetics
Plasma Concentrations and Blood Pressure Reduction
The relationship between plasma concentrations of metoprolol and its antihypertensive effects has been explored. One study found that steady-state plasma concentrations varied significantly between patients, correlating with the variability in blood pressure reduction and beta receptor blockade . However, another study indicated that single-dose kinetics were poor predictors of steady-state kinetics, emphasizing the importance of individualized dosing .
Extended-Release Formulations
Extended-release formulations of metoprolol, such as metoprolol CR/ZOK, have been shown to provide consistent blood pressure control over 24 hours. A study comparing once-daily metoprolol CR/ZOK (50 mg) with conventional metoprolol (50 mg twice daily) found equivalent reductions in blood pressure and heart rate, with fewer adverse events reported in the extended-release group 79.
Special Populations: Pediatric Use
Metoprolol has also been evaluated in pediatric populations. A clinical trial involving children aged 6 to 16 years demonstrated that extended-release metoprolol significantly reduced systolic and diastolic blood pressure at doses of 1.0 mg/kg and 2.0 mg/kg, with good tolerability and no serious adverse events .
Conclusion
Metoprolol is an effective antihypertensive agent with flexible dosing options. Both once-daily and twice-daily regimens are effective, with extended-release formulations offering the convenience of once-daily dosing and potentially fewer side effects. Dosages typically range from 50 mg to 300 mg daily, with individualized adjustments based on patient response and plasma concentration monitoring. For pediatric patients, extended-release metoprolol is a viable and well-tolerated option.
Sources and full results
Most relevant research papers on this topic